亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparison of alcohol septal ablation and mavacamten in patients with obstructive hypertrophic cardiomyopathy: a propensity-matched large single-center study

医学 酒精间隔消融 心脏病学 内科学 射血分数 心力衰竭 临床终点 房室传导阻滞 烧蚀 不利影响 心脏病 队列 梗阻性肥厚性心肌病 肥厚性心肌病 梗阻性心肌病 前瞻性队列研究 心肌病 射频消融术 心室流出道 队列研究 扩张型心肌病 代理终结点 心间隔 心房颤动
作者
Jan Koelemen,K Becht,Christoph Reich,Ali Amr,Elham Kayvanpour,Steffen Roßkopf,Norbert Frey,Benjamin Meder,Farbod Sedaghat‐Hamedani
出处
期刊:medRxiv
标识
DOI:10.64898/2026.08.18.26360764
摘要

Background Obstructive hypertrophic cardiomyopathy (oHCM) causes substantial symptom burden and impaired functional capacity. Mavacamten has emerged as a targeted pharmacologic treatment, whereas alcohol septal ablation (ASA) is an established septal reduction therapy (SRT). Direct comparative real-world data remain limited. Methods In this propensity-controlled observational study, longitudinal registry data from Heidelberg University Hospital were analyzed. Consecutive adults with oHCM, NYHA class ≥II symptoms, and a maximum LVOT gradient ≥50 mmHg treated with mavacamten or ASA were included. The cohort comprised 107 ASA- and 113 mavacamten-treated patients. Follow-up was performed at 6 and 12 months. The primary endpoint was a composite adverse clinical outcome including cardiovascular death, heart failure hospitalization, SRT, heart transplantation, ventricular assist device implantation, permanent pacemaker implantation for third-degree atrioventricular block, or decline in left ventricular ejection fraction to <40%. Results Both treatments showed significant improvement in NYHA class and LVOT gradient reduction over 12 months. Mean LVOT gradient decreased from 100.3 to 44.2 mmHg after ASA and from 85.7 to 18.4 mmHg with mavacamten at 12 months (both p<0.001). Between-group differences were not significant at 6 months, whereas residual LVOT gradient was lower with mavacamten at 12 months (p=0.004). NT-proBNP declined in both groups and was lower with mavacamten at both follow-up visits (both p<0.001). Third-degree atrioventricular block occurred more frequently after ASA (6.5% vs 0%, p=0.002). The composite endpoint occurred in 13 ASA-(12.1%) and 4 mavacamten-treated patients (3.5%) (p=0.003), with higher 1-year event-free survival in the mavacamten group (HR 0.19; 95%-CI 0.06-0.60; p=0.001). Conclusions In this real-world comparative study, both ASA and mavacamten improved symptoms and LVOT obstruction in oHCM. Mavacamten was associated with a more favorable short-term hemodynamic and safety profile at 12 months. Graphical abstract. Study design and principal findings of a propensity-matched single-center cohort study comparing alcohol septal ablation and mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
定海神针铁完成签到,获得积分10
1秒前
萧雨墨发布了新的文献求助10
2秒前
大模型的应助被开朗天问采纳,获得10
3秒前
带派不老铁完成签到 ,获得积分10
4秒前
坚强血茗完成签到 ,获得积分10
9秒前
10秒前
13秒前
suyongye完成签到,获得积分10
14秒前
熊猫四海完成签到 ,获得积分10
24秒前
科研通AI6.4的应助被YCLING采纳,获得10
27秒前
玖嬴完成签到,获得积分10
30秒前
Owen的应助被北极幸运星采纳,获得20
31秒前
可靠之玉发布了新的文献求助30
33秒前
helloWorld完成签到,获得积分10
35秒前
36秒前
kiki发布了新的文献求助10
40秒前
41秒前
萧雨墨发布了新的文献求助10
43秒前
44秒前
48秒前
pang完成签到,获得积分10
51秒前
51秒前
努力学习中完成签到,获得积分10
52秒前
余香的应助被萧雨墨采纳,获得10
55秒前
1分钟前
YCLING发布了新的文献求助10
1分钟前
1分钟前
infinity完成签到 ,获得积分10
1分钟前
小蘑菇的应助被从容问柳采纳,获得100
1分钟前
ubless607给成博的求助进行了留言
1分钟前
666完成签到 ,获得积分10
1分钟前
田様的应助被sissiarno采纳,获得10
1分钟前
共享精神的应助被sissiarno采纳,获得10
1分钟前
余香的应助被sissiarno采纳,获得10
1分钟前
1分钟前
嘻嘻哈哈的应助被sissiarno采纳,获得10
1分钟前
Nole完成签到,获得积分0
1分钟前
CipherSage的应助被sissiarno采纳,获得10
1分钟前
完美世界的应助被sissiarno采纳,获得10
1分钟前
ding的应助被sissiarno采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190049
求助须知:如何正确求助?哪些是违规求助? 9577165
关于积分的说明 21851842
捐赠科研通 7788131
什么是DOI,文献DOI怎么找? 3436227
关于科研通互助平台的介绍 2559910
邀请新用户注册赠送积分活动 2482768